Could Mini Labs and Plant-Based Vaccines Stop the Next Pandemic?

The H1N1 virus’s rapid spread worldwide last year exposed the weaknesses in the global system for swiftly developing, manufacturing and distributing vaccines for newly identified strains of influenza. In Texas, researchers are attacking the first two of these problems through Project GreenVax , which will use a plant-based approach to vaccine development and a modular manufacturing environment that can scale quickly as vaccine demand grows. [More]



Substack subscription form sign up
The material in this press release comes from the originating research organization. Content may be edited for style and length. Want more? Sign up for our daily email.